Saluda Medical shares plummet on Australian market debut – Reuters

  1. Saluda Medical shares plummet on Australian market debut  Reuters
  2. Biocurious: Saluda Medical’s IPO tackles the $35-billion-a-year chronic pain market  Stockhead
  3. Saluda Medical the latest Aussie-founded medtech set for an ASX debut after raising $231m  Business News Australia
  4. Saluda to expand spinal cord stimulation market in AU$231M IPO  BioWorld MedTech
  5. Johson Winter Slattery advises Saluda Medical, Inc. (ASX:SLD) on its IPO and ASX Listing  Johnson Winter Slattery

Continue Reading